Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AXA Regulatory Filings 2011

Mar 28, 2011

1135_iss_2011-03-28_fe358f36-8c2d-4494-8a19-d9403bba5334.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

AXA organizes the Global Forum for Longevity

  • An international and multi-disciplinary forum on the increase in life expectancy
  • First meetings of the Global Forum will be held today in Paris, webcasted on http://longevity.axa.com/en/
  • The AXA Research Fund dedicates additional € 10 million to fund Longevity research

AXA organizes today the Global Forum for Longevity, an initiative aming to encourage an exchange of knowledge around longevity.

As a focal point for debates and discussions between researchers, experts and decision-makers, the Global Forum for Longevity wishes to promote a more positive thinking on longevity and to work on the opportunities arising tha t have not yet been fully explored.

AXA takes this opportunity to announce as well that the AXA Research Fund has as an objective to devote €10 million within two years to fund projects aiming to better understand and grasp the consequences of the increase in life expectancy.

The AXA Research Fund has already allowed more than 50 researchers and research teams in France and throughout Europe to develop common knowledge on longevity.

"I am convinced that the increase in life expectancy is one of the main challenge of the 21st century, for both mature and emerging economies. Through its business, AXA is a priviliged witness of worldwide demographic and societal changes. Our responsibility is to stimulate the sharing of knowledge to help society to better understand the challenges of this demographic revolution and to fully benefit from the opportunités offered by longevity" said Henri de Castries, Chairman and CEO of AXA.

First meetings will take place today in Paris, notably around the following topics:

  • Longevity and emerging economies, with Robert B. Zoellick, President, World Bank Group,
  • Medical innovation, with Daniel Vasella, Chairman, Novartis,
  • Growth opportunities generated by the increase in life expectancy, with Eric Chaney, Chief Economist of the AXA Group, and Raphael Wittenberg 1 and Edward Whitehouse 2 , economists.

The whole program and the live webcast of the Global Forum are accessible on http://longevity.axa.com/en/.

1 Economist at the UK's Department of Health, Professor at the London School of Economics and Political Science (UK) 2 Head of Pension Policy Analysis in the Social Policy Division of the OECD (France)

About the Global Forum for Longevity

The increase in life expectancy is one of the mains challenges of the 21st century. This is why AXA Group has created the Global Forum for Longevity.

As a focal point for debates and discussions between researchers, experts and decision-makers, the Global Forum for Longevity aims to encourage the sharing of knowledge around this worldwide demographic evolution.

Through a multi-disciplinary, intergenerational and international approach, the objective is to gain understanding of the challenges related to longevity and to identify the opportunities arising, in order to allow everyone to regard this lifetime gain with ease.

This initiative is in line with AXA's efforts to support research initiatives focused on understanding and preventing the risks facing us, particularly with the AXA Research Fund.

Press kit and presentations of the actions initiated throughout the Global Forum for Longevity are available on http://longevity.axa.com/en/.

About the AXA Research Fund

The AXA Research Fund provides support for research focused on understanding and preventing the risks threatening the environment, human life and our societies. This major and innovative initiative of scientific philanthropy is endowed by the AXA Group with a 5-year budget of Euro 100 million.

As of February 1, 2011, Euro 48 million have been committed and the AXA Research Fund has given its support to 221 research projects, implemented in 19 countries by researchers of 40 nationalities. The funds are granted based on a decision by the Scientific Board, which is chaired by Ezra Suleiman and is made up of members of the academic world and AXA Group representatives.

More details about the AXA Research Fund, including presentation of the funding vehicles, guidelines and biographies of Scientific Board members, are available on the website www.axa-research.org.

About AXA

AXA Group is a worldwide leader in insurance and asset management, with 216,000 employees serving 93 million clients. In 2010, IFRS revenues amounted to Euro 91 billion and IFRS underlying earnings to Euro 3.9 billion.

AXA had Euro 1,104 billion in assets under management as of December 31, 2010.

The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISN FR 0000120628 – Bloomberg: CS FP – Reuters: AXAF.PA). AXA's American Depository Shares are also quoted on the OTC QX platform under the ticker symbol AXAHY.

The Group is included in the main international SRI indexes, such as Dow Jones Sustainability Index (DJSI) and FTSE4GOOD.

This press release is available on the AXA Group website: www.axa.com

AXA Media Relations:

Armelle Vercken: +33.1.40.75.46.42
Sara Gori: +33.1.40.75.48.17
Guillaume Borie: +33.1.40.75.49.98
Hélène Caillet: +33.1.40.75.55.51
Brice Le Roux: +33.1.40.75.57.26